Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Nephrology

John Weinberg, MD, COO, Veloxis Pharmaceuticals, talks about the challenges in current organ transplantation methods, and Veloxis’ once-daily solution to advancing kidney transplantation. According to Weinberg, most kidney transplants fail in the...
A drug developed by Amicus Therapeutics, Inc. has shown to be as effective as enzyme replacement therapy in patients with Fabry disease, according to an article published by Reuters. The drug, called migalastat HCl, recently finished a second...
Donating a kidney may put you at a greater risk for end-stage renal disease (ESRD) compared to similarly screened health non-donors, CNN News reports. The finding is based on a study published in JAMA that compared living kidney donors to “healthy...